Apalutamide

CAS 955881-14-9 14 API suppliersSmall Molecule

Overview

Apalutamide is a nonsteroidal antiandrogen used in the treatment of prostate cancer. It works by inhibiting the action of androgens (male hormones) that can promote tumor growth.

API suppliers (14)

Suppliers of Apalutamide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India6China6

Country recorded for 12 of 14 suppliers.

9 of 14 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (3 approved US products), the latest listed US patent on Apalutamide expires 14 Jan 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

OncologyProstate CancerEndocrinology
Verified Supplier Partner

Do you supply Apalutamide? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.